FDA DEVICE FACTS
Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate (Blue); Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate (Black)
Hartalega NGC Sdn. Bhd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drug and Fentanyl Citrate (Blue) is a non-sterile disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. It is also tested to be used against Chemotherapy Drugs and Fentanyl Citrate. The list of Chemotherapy Drugs tested (with breakthrough time) are: Chemotherapy Drug and Concentration / Minimum Breakthrough Detection Time in Minutes Carmustine (3.3 mg/ml): 20.0 Cisplatin (1.0 mg/ml): >240 Cyclophosphamide (Cytoxan) (20.0 mg/ml): >240 Dacarbazine (10.0 mg/ml): >240 Doxorubicin Hydrochloride (2.0 mg/ml): >240 Etoposide (Toposar) (20.0 mg/ml): >240 Fluorouracil (50.0 mg/ml): >240 Methotrexate (25.0 mg/ml): >240 Mitomycin C (0.5 mg/ml): >240 Paclitaxel (Taxol) (6.0 mg/ml): >240 Thiotepa (10.0 mg/ml): 54.0 Vincristine Sulfate (1.0 mg/ml): >240 5-Azacytidine (25.0 mg/ml): >240 Carboplatin (10.0 mg/ml): >240 Docetaxel (10 mg/ml): >240 Epirubicin (2.0 mg/mL): >240 Gemcitabine (38 mg/ml): >240 Ifosfamide (50 mg/ml): >240 Irinotecan (20 mg/ml): >240 Mitoxantrone (2.0 mg/ml): >240 Oncovin (1.0 mg/ml): >240 Oxaliplatin (5 mg/ml): >240 Vinorelbine (10 mg/ml): >240 Caution: Testing showed a minimum breakthrough time of 20.0 minutes with Carmustine and 54.0 minutes with Thiotepa. Warning: Do not use with Carmustine. Fentanyl Citrate Injection (100 mcg/2ml): >240 minutes minimum breakthrough detection time. Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drug and Fentanyl Citrate (Black) is a non-sterile disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. It is also tested to be used against Chemotherapy Drugs and Fentanyl Citrate. The list of Chemotherapy Drugs tested (with breakthrough time) are: Chemotherapy Drug and Concentration / Minimum Breakthrough Detection Time in Minutes Carmustine (3.3 mg/ml): 25.0 Cisplatin (1.0 mg/ml): >240 Cyclophosphamide (Cytoxan) (20.0 mg/ml): >240 Dacarbazine (10.0 mg/ml): >240 Doxorubicin Hydrochloride (2.0 mg/ml): >240 Etoposide (Toposar) (20.0 mg/ml): >240 Fluorouracil (50.0 mg/ml): >240 Methotrexate (25.0 mg/ml): >240 Mitomycin C (0.5 mg/ml): >240 Paclitaxel (Taxol) (6.0 mg/ml): >240 Thiotepa (10.0 mg/ml): 55.7 Vincristine Sulfate (1.0 mg/ml): >240 5-Azacytidine (25.0 mg/ml): >240 Carboplatin (10.0 mg/ml): >240 Docetaxel (10 mg/ml): >240 Epirubicin (2.0 mg/mL): >240 Gemcitabine (38 mg/ml): >240 Ifosfamide (50 mg/ml): >240 Irinotecan (20 mg/ml): >240 Mitoxantrone (2.0 mg/ml): >240 Oncovin (1.0 mg/ml): >240 Oxaliplatin (5 mg/ml): >240 Vinorelbine (10 mg/ml): >240 Caution: Testing showed a minimum breakthrough time of 25.0 minutes with Carmustine and 55.7 minutes with Thiotepa. Warning: Do not use with Carmustine. Fentanyl Citrate Injection (100 mcg/2ml): >240 minutes minimum breakthrough detection time.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。